• Cloud Storage for Enterprise IT

    Jan 3, 2013, 11:00 AM by Michael Croft
    Computerworld | Gartner says that cloud storage is a viable alternative to traditional options, but not all providers can meet the needs of enterprise IT.
    Full story

  • FDA Approves Record Number of Drugs

    Jan 2, 2013, 13:00 PM by Michael Croft
    Bloomberg | FDA closed a record year this week; US drug approvals in 2012 reached their highest level in 15 years. The Food and Drug Administration cleared 39 novel medicines last year.
    Full story

  • Predictions of Medicine's Future

    Jan 2, 2013, 12:00 PM by Michael Croft
    Wall Street Journal | At the intersection of medicine and technology, six innovations are poised to transform medicine: growing a heart, DNA sequencing in the clinic, matching tumors to drugs, smartphone health care, gene therapy, and more.
    Full story

  • Omicia Names New CEO, Prepares Genome Interpretation Platform Launch

    Jan 2, 2013, 11:00 AM by Michael Croft
    Fort Mills Times | Omicia (a 2012 Bio-IT World Best Practices awards winner) has appointed Mike Aicher as CEO.
    Full story

  • Genomics 2012: Narcissomes, Neonates and ENCODE

    Jan 2, 2013, 08:00 AM by Michael Croft
    Bio-IT World | FIRST BASE | From clinical exomes to the clamor over the ENCODE Project, 2012 was a packed year for genomics in both the research and clinical arena, and seemingly sets the stage for a barnstorming, anniversary-rich 2013.
    Full story

  • BGI-Complete Deal Gets Security Clearance

    Jan 2, 2013, 07:00 AM by Michael Croft
    New York Times | The U.S. Government has granted national security clearance to the BGI-Complete Genomics deal. The Committee on Foreign Investment in the United States, which reviews the national security implications of foreign takeovers of American companies, gave its approval to the deal over the weekend.
    Full story

  • Encyclopedia Genomica: UK Scientists Print the Book of Life in 130 Volumes

    Dec 28, 2012, 10:00 AM by Michael Croft
    Bio-IT World | Nowadays it is cheaper to sequence the human genome than to print out a full hard copy. We know this because earlier this year, Cas Kramer and a group of scientists at the University of Leicester decided to print out a complete version of the human genome.
    Full story

  • Parexel Acquires Regulatory Information Management Software

    Dec 28, 2012, 08:00 AM by Michael Croft
    Boston Business Journal | Parexel has acquired Liquent, a provider of regulatory information management software, for $72 million. Parexel says the acquisition will give its clients access to Liquent's InSight software.
    Full story

  • 2013 - The Year of Data-Driven Decisions

    Dec 27, 2012, 07:00 AM by Michael Croft
    Bio-IT World | Guest Commentary | Clinical trials (for the most part) are run by talented study managers who rely on experience, anecdotal knowledge, and "gut" instinct to plan and execute them.  While these study managers get trials over the finish line as close as possible to plan, it’s reckless and increasingly difficult to take a cottage-industry approach to managing these multi-million dollar projects.  As trials become more complex, expand globally and extend into new markets, even the most experienced and talented study managers struggle, resulting in highly unpredictable trial costs and timelines across the portfolio.  It’s time to take a fresh approach.
    Full story

  • IT Spending in 2013

    Dec 26, 2012, 09:00 AM by Michael Croft
    eWeek | With about half IT heads expecting a budget increase in 2013, outsourced IT resources (read: cloud) and wireless technologies will probably account for most of the increased spending.
    Full story

  • 2012 in Review: Sequencing and Personalized Medicine

    Dec 26, 2012, 08:00 AM by Michael Croft
    Technology Review | Technology Review covers the year's advances in biomedicine. Sequencing continues to get cheaper and more accessible and its implications for medicine continue to evolve.
    Full story

  • 2012 in Review: Cloud Computing and IT

    Dec 26, 2012, 08:00 AM by Michael Croft
    Computerworld | The year of the cloud. Three new major players entered the Infrastructure-as-a-Service scene--Google, HP, and Microsoft--but Amazon kept its #1 spot.
    Full story

  • AWS Data Pipeline Ready for Use

    Dec 21, 2012, 08:00 AM by Michael Croft
    AWS Blog | Amazon Web Services has launched its Data Pipeline. The new services allows users to automate the movement and processing of any amount of data using data-driven workflows and built-in dependency checking.
    Full story

  • Roche Bids Again for Illumina?

    Dec 21, 2012, 08:00 AM by Michael Croft
    Bloomberg | A Swiss newspaper is reporting that Roche and Illumina may have come to a purchase agreement, eight months after Illumina rejected Roche's last proposed bid. The two companies will announce a January $66/share sale price, the paper reported.
    Full story

  • Going Long vs Going for the Sale

    Dec 20, 2012, 09:00 AM by Michael Croft
    Xconomy | Do biotechs today have a long term plan or vision? Should they? With Big Pharma seemingly always on the hunt for new technologies and targets to snatch up, do you need a long term plan?
    Full story

  • December Product and News Briefs

    Dec 20, 2012, 07:00 AM by Michael Croft
    Bio-IT World | Briefs for December include new products from Linguamatics, PerkinElmer, Titan Software, SoftGenetics, and Optibrium; industry news from IBM, Agilent, CLC bio and an internship opportunity in Singapore; a free trial from Partek; and more.  
    Full story

  • Challenges and Luck in Clinical Genomics

    Dec 19, 2012, 10:00 AM by Michael Croft
    Milwaukee-Wisconsin Journal Sentinel | Three years after Nic Volker, researchers and physicians discussed advances and challenges in genomic medicine this week at Marquette University. Today, the sequeincing and analysis that saved Volker can be done in a couple of days, but that hasn't made it mainstream.
    Full story

  • Amgen Guilty of Off-Label Marketing, $762m Fine

    Dec 19, 2012, 09:00 AM by Michael Croft
    LA Times | Amgen pleaded guilty in federal court to improper marketing of its anemia drug Aranesp and has agreed to $762 million in fines and settlements. Prosecutors said the company was encouraging doctors to use its popular anemia drug for unapproved uses in efforts to boost its bottom line.
    Full story

  • Broad Institute Names Matthew Trunnell New CIO

    Dec 18, 2012, 12:00 PM by Michael Croft
    Bio-IT World | Matthew Trunnell has been named the new chief information officer (CIO) of the Broad Institute, effective January 4, 2013.
    Full story

  • 2013 Enterprise Sofware Predictions

    Dec 18, 2012, 07:55 AM by Michael Croft
    Computerworld | Computerworld lays out its predictions for enterprise software vendors and users in 2013. Among them: heavy investment in mobility, an Oracle pullback on hardware, more momentum for Hadoop, and clouds, clouds, clouds.
    Full story